Manulife (Manufacturers Life Insurance)’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
58,251
-20,881
| -26% | -$3.6M | 0.01% | 842 |
|
|
2025
Q1 | $12.3M | Sell |
79,132
-3,823
| -5% | -$596K | 0.01% | 753 |
|
|
2024
Q4 | $11.4M | Buy |
82,955
+11,648
| +16% | +$1.6M | 0.01% | 818 |
|
|
2024
Q3 | $10.6M | Buy |
71,307
+23,595
| +49% | +$3.52M | 0.01% | 871 |
|
|
2024
Q2 | $6.51M | Sell |
47,712
-6,814
| -12% | -$929K | 0.01% | 1048 |
|
|
2024
Q1 | $8.24M | Buy |
54,526
+31,738
| +139% | +$4.8M | 0.01% | 951 |
|
|
2023
Q4 | $2.87M | Sell |
22,788
-2,785
| -11% | -$351K | ﹤0.01% | 1357 |
|
|
2023
Q3 | $2.39M | Sell |
25,573
-19,716
| -44% | -$1.85M | ﹤0.01% | 1381 |
|
|
2023
Q2 | $4.04M | Sell |
45,289
-5,739
| -11% | -$512K | ﹤0.01% | 1189 |
|
|
2023
Q1 | $5.47M | Hold |
51,028
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q4 | $6.17M | Buy |
51,028
+387
| +0.8% | +$46.8K | ﹤0.01% | 978 |
|
|
2022
Q3 | $5.2M | Buy |
50,641
+6,606
| +15% | +$678K | ﹤0.01% | 1026 |
|
|
2022
Q2 | $4.15M | Buy |
44,035
+2,569
| +6% | +$242K | ﹤0.01% | 1173 |
|
|
2022
Q1 | $4.81M | Buy |
+41,466
| New | +$4.81M | ﹤0.01% | 1208 |
|